Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Omkar PharmachemBOM:532167 52 Quick Ratio is 5.96 as of Mar. 2026, which is 1556% above its 10-year median of 0.36. GuruFocus rates BOM:532167 with a GF Score™ of 52/100 and a GF Value™ of ₹23.90 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 1,090 Business Services companies, Omkar Pharmachem ranks better than 93.03% on this metric.
Omkar Pharmachem has a quick ratio of 5.96. It generally indicates good short-term financial strength.
The historical rank and industry rank for Omkar Pharmachem's Quick Ratio or its related term are showing as below:
BOM:532167'
s Quick Ratio Range Over the Past 10 Years
Min: 0.03 Med: 0.36 Max: 5.96
Current: 5.96
During the past 13 years, Omkar Pharmachem's highest Quick Ratio was 5.96. The lowest was 0.03. And the median was 0.36.
BOM:532167's Quick Ratio is ranked better than 93.03% of 1090
companies
in the Business Services industry
Industry Median: 1.67
vs BOM:532167: 5.96
Omkar Pharmachem (BOM:532167) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Omkar Pharmachem Quick Ratio Related Terms
Omkar Pharmachem Quick Ratio Historical Data
* Premium members only.
The historical data trend for Omkar Pharmachem's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:532167 vs CTAS, CPRT, GPN: Quick Ratio Comparison
For the Specialty Business Services subindustry, Omkar Pharmachem's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omkar Pharmachem Quick Ratio vs Business Services Industry
For the Business Services industry and Industrials sector, Omkar Pharmachem's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Omkar Pharmachem's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Omkar Pharmachem's Quick Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Omkar Pharmachem (BOM:532167) has a Quick Ratio of 5.96 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Omkar Pharmachem and its competitors. This is 1556% above median its historical median of 0.36. Over the past decade, Omkar Pharmachem's Quick Ratio has ranged from 0.03 to 5.96. According to the industry distribution chart, Omkar Pharmachem ranks #76 out of 1090 companies in the Business Services industry, placing it in the top 7%.
Is Omkar Pharmachem's Quick Ratio too high?
Omkar Pharmachem's current Quick Ratio of 5.96 is 1556% above median its 10-year median of 0.36. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 5.96. The Business Services industry median Quick Ratio is 1.67. Omkar Pharmachem's value of 5.96 is 256.9% above this industry median. Based on the distribution chart, Omkar Pharmachem ranks #76 out of 1090 companies in the Business Services industry, which is in the top quartile — a strong position relative to peers. Overall, Omkar Pharmachem has a GF Score™ of 52/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Omkar Pharmachem's Quick Ratio compare to CTAS and CPRT?
According to the Business Services industry distribution chart, Omkar Pharmachem ranks #76 out of 1090 companies for Quick Ratio. This places Omkar Pharmachem in the top 7% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.67. Omkar Pharmachem's value of 5.96 is 256.9% above this benchmark. Historically, Omkar Pharmachem's own Quick Ratio has ranged from 0.03 to 5.96 over the past decade. While the company's 10-year median is 0.36 vs. the industry median of 1.67, Omkar Pharmachem has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Business Services company?
The median Quick Ratio among Business Services companies is 1.67, based on 1,090 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Omkar Pharmachem's current Quick Ratio of 5.96 is 256.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Omkar Pharmachem and its competitors. For the Business Services industry, the median Quick Ratio is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omkar Pharmachem's current Quick Ratio is 5.96, which is 1556% above median its own 10-year median of 0.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omkar Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Omkar Pharmachem (BOM:532167) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹23.90, compared to a current price of ₹16.30 — trading 31.8% below its estimated fair value. The current Quick Ratio is 5.96, which is 1556% above median its 10-year median of 0.36 and 256.9% above the Business Services industry median of 1.67. Omkar Pharmachem's overall GF Score™ is 52/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Omkar Pharmachem (BOM:532167), the current Quick Ratio is 5.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Omkar Pharmachem (BOM:532167) Overvalued in 2026?
Based on GuruFocus' analysis, Omkar Pharmachem stock appears to be undervalued.
The current stock price of ₹16.30 is trading 31.8% below its estimated GF Value™ of ₹23.90.
GuruFocus considers Omkar Pharmachem to be Significantly Undervalued.
Key valuation signals for BOM:532167:
Quick Ratio: 5.96 (1556% above median its 10-year median of 0.36)
GF Value™: ₹23.90 vs. price of ₹16.30 (31.8% below fair value)
Industry Position: 256.9% above the Business Services median (#76 of 1090)
No single metric tells the full story. See the BOM:532167 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532167 has been successfully added to your 
